immunotherapy

The team identified specific proteins — fibronectin and smooth muscle actin — associated with resistance to immunotherapy treatment in colorectal cancer tissues.

Researchers have discovered a new role that a protein known as NKG7 plays in regulating cell resistance and fighting tumors in certain types of cancer.

Drs. Haidong Dong and Svetomir Markovic, Mayo Clinic immunologists, discuss how immunotherapy works, its benefits and risks, and why they’re excited about its future.

Dr. Keith Knutson discusses lung cancer vaccine research at Mayo Clinic and how physicians might use vaccines for other types of cancer.

Systemic therapies for breast cancer include chemotherapy, hormone therapy, targeted-drug therapy and immunotherapy. Dr. Matthew Goetz provides an overview.

Researchers at Mayo Clinic are studying a vaccine-immunotherapy combination to stop ovarian cancer from progressing.

Findings can assist care teams in predicting if someone with advanced colorectal cancer will benefit from immunotherapy.

Hematologist Dr. Yi Lin discusses the use of immunotherapies and other novel approaches to treating multiple myeloma.

The story of how Dawn Botsford conquered melanoma with the support of her family, her Mayo Clinic care team and a clinical trial.

Researchers are investigating whether immunotherapy benefits people with esophageal and gastric cancers that have not spread to distant organs.